H. Yang Et Al. , "IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1," JOURNAL OF IMMUNOLOGY , vol.175, no.3, pp.2018-2025, 2005
Yang, H. Et Al. 2005. IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1. JOURNAL OF IMMUNOLOGY , vol.175, no.3 , 2018-2025.
Yang, H., Tuzun, E., Alagappan, D., Yu, X., Scott, B., Ischenko, A., ... Christadoss, P.(2005). IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1. JOURNAL OF IMMUNOLOGY , vol.175, no.3, 2018-2025.
Yang, H Et Al. "IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1," JOURNAL OF IMMUNOLOGY , vol.175, no.3, 2018-2025, 2005
Yang, H Et Al. "IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1." JOURNAL OF IMMUNOLOGY , vol.175, no.3, pp.2018-2025, 2005
Yang, H. Et Al. (2005) . "IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1." JOURNAL OF IMMUNOLOGY , vol.175, no.3, pp.2018-2025.
@article{article, author={H Yang Et Al. }, title={IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1}, journal={JOURNAL OF IMMUNOLOGY}, year=2005, pages={2018-2025} }